iiinova — where your digital self keeps evolving

GRAIL, Inc. @grailbio.bsky.social · 07/04/2026

Today we announced a collaboration with EPIC to integrate the Galleri multi-cancer early detection (#MCED) test into EPIC’s electronic health record (EHR) platform, supporting broader adoption across the US #HealthSystems. Read the press release: bit.ly/4vmIMjs

000

GRAIL, Inc. @grailbio.bsky.social · 20/03/2026

Seven in 10 cancer deaths in the US are from cancer types with no recommended screenings, including pancreatic, liver, ovarian, and esophageal cancers. Multi-cancer early detection (#MCED) testing offers a path to find more cancers, earlier. Learn more: bit.ly/45phhKK

000

GRAIL, Inc. @grailbio.bsky.social · 16/02/2026

We will announce fourth quarter and full year 2025 financial results on February 19. Register for the webcast: bit.ly/4rZLqcp Read more: bit.ly/3MHOevD

000

GRAIL, Inc. @grailbio.bsky.social · 03/02/2026

Following the President’s signature, the Nancy Gardner Sewell Medicare MCED Screening Coverage Act is now law, establishing a Medicare benefit category for MCED tests and a path to meaningful coverage once MCED tests are FDA approved. Learn more: bit.ly/45OQPdv

010

GRAIL, Inc. @grailbio.bsky.social · 23/01/2026

Listen to Dr. Robert Merritt, a thoracic surgeon who helped treat Fire Lieutenant Kevin McFarland’s stage 1 cancer, discuss multi-cancer early detection (MCED) testing and the importance of #EarlyCancerDetection on the latest episode of The Cancer SIGNAL podcast: bit.ly/48PiKfd #MCED

020

GRAIL, Inc. @grailbio.bsky.social · 08/01/2026

We’re taking the stage at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12 at 7:30 a.m. PT. Live and replay webcasts will be available. Learn more and how to watch: bit.ly/455zjkM #JPMHealth #JPM2026

110

GRAIL, Inc. @grailbio.bsky.social · 08/12/2025

Kevin McFarland, a lieutenant with his local fire department, took a multi-cancer early detection (MCED) test that led to a stage 1 diagnosis. Hear how this experience helped renew his appreciation for his health on the latest episode of The Cancer SIGNAL podcast: #EarlyCancerDetection #MCED

000

GRAIL, Inc. @grailbio.bsky.social · 02/12/2025

We’re presenting new research at the upcoming #SUO2025 meeting. Our abstract presentation will reveal findings on the non-invasive detection of residual urothelial carcinoma using cell-free DNA methylation in pre-op urine and plasma samples. Join us: bit.ly/4qNzLgT

000

GRAIL, Inc. @grailbio.bsky.social · 20/11/2025

Early stage pancreatic cancer often goes undetected, resulting in many people being diagnosed after the cancer has advanced.This Pancreatic Cancer Awareness Day, help us spread the word that #EarlyCancerDetection saves lives. #PancreaticCancerAwareness

000

GRAIL, Inc. @grailbio.bsky.social · 12/11/2025

Today GRAIL reported third quarter 2025 financial results. Learn more: bit.ly/47RXsfr

000

GRAIL, Inc. @grailbio.bsky.social · 07/11/2025

Join us next Thursday for GRAIL’s Analyst Day 2025. Register and watch the live webcast here: bit.ly/47K19Ue

000

GRAIL, Inc. @grailbio.bsky.social · 23/10/2025

On the latest episode of The Cancer SIGNAL podcast, host Susanna Quinn is joined by Nima Nabavizadeh, MD, from Oregon Health & Science University, to discuss the groundbreaking PATHFINDER 2 study findings. Listen here: bit.ly/48DGcwp #EarlyCancerDetection #MCED

020

GRAIL, Inc. @grailbio.bsky.social · 20/10/2025

Today we announced that we have entered into a securities purchase agreement for a private placement that is expected to result in gross proceeds of approximately $325.0 million, before deducting placement agents’ fees and other expenses. Learn more: grail.com/press-releas...

000

GRAIL, Inc. @grailbio.bsky.social · 19/10/2025

70% of cancer deaths are from cancers that do not have recommended screening tests. In the PATHFINDER 2 study, presented at #ESMO25, approximately three-quarters of the cancers detected by Galleri do not have standard of care screening options. Learn more: bit.ly/4n91cP6

000

GRAIL, Inc. @grailbio.bsky.social · 19/10/2025

Press following #ESMO25: Join the Press Briefing II - today, 12:30-13:15 CEST, as Dr. Nima Nabavizadeh discusses “Safety and Performance of a Multi-Cancer Early Detection (MCED) Test in an Intended-Use Population: Initial Results from the Registrational PATHFINDER 2 Study.”

000

GRAIL, Inc. @grailbio.bsky.social · 17/10/2025

Coming up tomorrow at #ESMO25 in Berlin - results from the PATHFINDER 2 study. See our press release for more details: bit.ly/4n91cP6

000

GRAIL, Inc. @grailbio.bsky.social · 14/10/2025

It’s #MensBreastCancerAwareness Week, an ideal time to remind everyone that, while rare, #MenGetBreastCancerToo—and they should see their doctor immediately if they notice any unusual symptoms. #EarlyDetection can help improve their chances for successful treatment.

010

GRAIL, Inc. @grailbio.bsky.social · 10/10/2025

#LiverCancer is the fourth most common cause of cancer death worldwide, and hepatocellular carcinoma (HCC), which accounts for nearly 75% of all cases, is often diagnosed in advanced stages. We’re observing #LiverCancerAwarenessMonth by promoting #EarlyDetection. #OctoberIs4Livers

000

GRAIL, Inc. @grailbio.bsky.social · 07/10/2025

After 20 years of serving her local police department, Darla took a multi-cancer early detection (MCED) test through her insurance company. Despite having no symptoms, her test detected a cancer signal, giving her the chance to take swift action and become cancer free today. bit.ly/47aCE3o

000

GRAIL, Inc. @grailbio.bsky.social · 06/10/2025

How do we bring multi-cancer early detection (MCED) into everyday clinical practice? With more than 35,000 participants, PATHFINDER 2 is the largest U.S. interventional MCED study to date. Ahead of #ESMO25, our president, Dr. Josh Ofman, shares what these data mean: bit.ly/46EECck

010

GRAIL, Inc. @grailbio.bsky.social · 01/10/2025

For #BreastCancerAwarenessMonth, we’re calling out the importance of #EarlyDetection—especially if you’re at risk for the BRCA gene mutation. Learn more by listening to The Cancer SIGNAL: bit.ly/4pTkTxc

000

GRAIL, Inc. @grailbio.bsky.social · 30/09/2025

Celebrate #InternationalPodcastDay by giving The Cancer SIGNAL a listen. On this podcast, we dive into the stories behind multi-cancer early detection (MCED)—from patients to doctors, advocates to researchers, and more. Tune in today: bit.ly/47oQpMD #PodcastCommunity #EarlyCancerDetection

000

GRAIL, Inc. @grailbio.bsky.social · 26/09/2025

#GynecologicCancerAwarenessMonth serves as a reminder of the importance of routine screenings for detecting cervical cancer early and improving prognosis and treatment success. #GCAM #PreventCervicalCancer

000

GRAIL, Inc. @grailbio.bsky.social · 24/09/2025

Tad Carper, a @dallas--cowboys.bsky.social exec, took a multi-cancer early detection (MCED) test—which led to an unexpected journey. Hear how early detection shaped his story on the latest episode of The Cancer SIGNAL podcast: Apple Podcasts: apple.co/4mI2WPm

000

GRAIL, Inc. @grailbio.bsky.social · 23/09/2025

We’re presenting new data from our PATHFINDER 2 study at the European Society for Medical Oncology 2025 Congress. We are also pleased to be sharing results from our SYMPLIFY and REFLECTION studies at the 2025 Early Detection of Cancer Conference. Read more: bit.ly/4nc39Lu #ESMO25

010

GRAIL, Inc. @grailbio.bsky.social · 15/09/2025

You can observe #WorldLymphomaAwarenessDay by putting your health first and paying attention to unusual symptoms—especially if you’re at high risk for lymphoma—as well as getting regular checkups. Remember that early detection can help ensure more treatment options. #WLAD

000

GRAIL, Inc. @grailbio.bsky.social · 09/09/2025

A few compelling numbers in time for Ovarian Cancer Awareness Month: Stage I can be cured in up to 90% of cases, and stage II has a 5-year survival rate of 70%. Yet only 20% are diagnosed at stage I or II, underscoring the need to raise awareness of early detection. #OvarianCancer #OCAM

000

GRAIL, Inc. @grailbio.bsky.social · 04/09/2025

Were you aware that while the overall cancer death rate decreased by 34% from 1991 to 2022, the leukemia rate has increased? In observance of Blood Cancer Awareness Month, we’re highlighting the importance of early detection. #BloodCancerAwareness #Leukemia

000

GRAIL, Inc. @grailbio.bsky.social · 12/08/2025

Today GRAIL reported second quarter 2025 financial results. Learn more: grail.com/press-releas...

000

GRAIL, Inc. @grailbio.bsky.social · 08/07/2025

July is Sarcoma Awareness Month—a time to raise awareness about rare cancers and the importance of early detection. Cancer screenings and a knowledge of symptoms can lead to earlier diagnoses and better treatment outcomes. #SarcomaAwareness #EarlyCancerDetection

000

GRAIL, Inc. @grailbio.bsky.social · 18/06/2025

Today we announced positive top-line performance and safety results from our registrational PATHFINDER 2 study. Learn more: grail.com/press-releas...

000

GRAIL, Inc. @grailbio.bsky.social · 30/05/2025

Lieutenant McFarland, a healthy firefighter, took an #MCED test, leading to a stage 1 #EsophagealCancer diagnosis after diagnostic evaluation. Early detection allowed for a minimally invasive procedure to remove the tumor, helping him avoid chemo and radiation. youtu.be/S7pBNtnxl4w

youtu.be

Patient Testimonial: Kevin, Cancer Signal Detected

YouTube video by GRAIL

000

GRAIL, Inc. @grailbio.bsky.social · 13/05/2025

Today GRAIL reported first quarter 2025 financial results. Learn more: grail.com/press-releas...

000

GRAIL, Inc. @grailbio.bsky.social · 12/05/2025

Today we announced a new partnership with athenahealth, which will offer healthcare providers streamlined ordering of the Galleri multi-cancer early detection (MCED) test. Learn more: grail.com/press-releas...

000

GRAIL, Inc. @grailbio.bsky.social · 09/05/2025

GRAIL is the 2025 Best Overall MedTech Company! We are so proud of this recognition from the 9th annual MedTech Breakthrough Awards program, which is designed to honor excellence and recognize innovation, hard work, and success in a range of health and medical technology categories.

000

GRAIL, Inc. @grailbio.bsky.social · 08/05/2025

Only ~20% of ovarian cancers are found at an early stage. And there are no recommended screening tests for people who aren’t at high risk and who do not have symptoms. This #WorldOvarianCancerDay, hear The Cancer SIGNAL host Susanna Quinn’s experience with ovarian cancer: bit.ly/3RVVzqr

000

GRAIL, Inc. @grailbio.bsky.social · 01/05/2025

There are currently no standard #BladderCancer screening tests for people at average risk. This #BladderCancerAwarenessMonth, learn more about the potential of multi-cancer early detection (MCED) testing in screening for cancer: Rx only. See Important Safety Information: grail.com/multi-cancer...

000

GRAIL, Inc. @grailbio.bsky.social · 22/04/2025

We’re excited to attend the @theaacr.bsky.social Annual Meeting (AACR) to present new data findings that highlight real-world evidence with the Galleri multi-cancer early detection (MCED) test. See when and where you can find our data presentations: grail.com/press-releas... #AACR25

010

GRAIL, Inc. @grailbio.bsky.social · 22/04/2025

This Medical Laboratory Professionals Week, we are recognizing the important work our clinical laboratory personnel and professionals do in the fight against cancer. Thank you for your invaluable contribution to our mission. #MLPW #lab4life #labweek

011

GRAIL, Inc. @grailbio.bsky.social · 03/04/2025

Today we welcomed several cancer advocacy organizations to our NC site to tour our state-of-the-art lab and meet with GRAIL senior leaders. It was an incredible opportunity to share our innovative work and explore what is needed to support those impacted by cancer.

000

GRAIL, Inc. @grailbio.bsky.social · 20/02/2025

Today GRAIL reported fourth quarter and full year 2024 financial results. Read more: grail.com/press-releas...

000

GRAIL, Inc. @grailbio.bsky.social · 14/02/2025

Gracie learned about multi-cancer early detection (MCED) testing through a workplace bulletin, offering it as a benefit. Though she had no symptoms of cancer, she took the test and was surprised to receive a Cancer Signal Detected result. Rx only. See Important Safety Information: bit.ly/3QHmPWo

youtu.be

Patient Testimonial: Gracie – Cancer Signal Detected, Breast Cancer

YouTube video by GRAIL

000